Ruhnke M - Search Results

1

[Molecular epidemiology of Candida infections in HIV-infected mothers and their offspring].

Ruhnke M, Grosch-Wörner I, Steinmüller A, Neubauer A. Ruhnke M, et al. Wien Med Wochenschr. 1997;147(19-20):446-9. Wien Med Wochenschr. 1997. PMID: 9471841 German.

2

Ruhnke M, Grosch-Wörner I, Lischewski A, Neubauer A, Steinmüller A, Trautmann M, Morschhäuser J. Ruhnke M, et al. Mycoses. 1999;42(5-6):385-94. doi: 10.1046/j.1439-0507.1999.00479.x. Mycoses. 1999. PMID: 10536430

3

[Comparison of three antifungal susceptibility testing methods for the in vitro testing of Candida isolates from patients with HIV infection].

Ruhnke M, Schmidt-Westhausen A, Trautmann M. Ruhnke M, et al. Mycoses. 1996;39 Suppl 2:47-50. doi: 10.1111/j.1439-0507.1996.tb00528.x. Mycoses. 1996. PMID: 9198745 German.

4

In vitro activities of voriconazole (UK-109,496) against fluconazole-susceptible and -resistant Candida albicans isolates from oral cavities of patients with human immunodeficiency virus infection.

Ruhnke M, Schmidt-Westhausen A, Trautmann M. Ruhnke M, et al. Antimicrob Agents Chemother. 1997 Mar;41(3):575-7. doi: 10.1128/AAC.41.3.575. Antimicrob Agents Chemother. 1997. PMID: 9055995 Free PMC article.

5

Development of simultaneous resistance to fluconazole in Candida albicans and Candida dubliniensis in a patient with AIDS.

Ruhnke M, Schmidt-Westhausen A, Morschhäuser J. Ruhnke M, et al. J Antimicrob Chemother. 2000 Aug;46(2):291-5. doi: 10.1093/jac/46.2.291. J Antimicrob Chemother. 2000. PMID: 10933656

6

Epidemiology of Candida albicans infections and role of non-Candida-albicans yeasts.

Ruhnke M. Ruhnke M. Curr Drug Targets. 2006 Apr;7(4):495-504. doi: 10.2174/138945006776359421. Curr Drug Targets. 2006. PMID: 16611037 Review.

7

Correlation between antifungal susceptibility testing of Candida isolates from patients with HIV infection and clinical results after treatment with fluconazole.

Ruhnke M, Eigler A, Engelmann E, Geiseler B, Trautmann M. Ruhnke M, et al. Infection. 1994 Mar-Apr;22(2):132-6. doi: 10.1007/BF01739024. Infection. 1994. PMID: 8070927 Clinical Trial.

8

Comparative evaluation of three antifungal susceptibility test methods for Candida albicans isolates and correlation with response to fluconazole therapy.

Ruhnke M, Schmidt-Westhausen A, Engelmann E, Trautmann M. Ruhnke M, et al. J Clin Microbiol. 1996 Dec;34(12):3208-11. doi: 10.1128/jcm.34.12.3208-3211.1996. J Clin Microbiol. 1996. PMID: 8940474 Free PMC article.

9

Emergence of fluconazole-resistant strains of Candida albicans in patients with recurrent oropharyngeal candidosis and human immunodeficiency virus infection.

Ruhnke M, Eigler A, Tennagen I, Geiseler B, Engelmann E, Trautmann M. Ruhnke M, et al. J Clin Microbiol. 1994 Sep;32(9):2092-8. doi: 10.1128/jcm.32.9.2092-2098.1994. J Clin Microbiol. 1994. PMID: 7814530 Free PMC article.

10

[Fluconazole in therapy of candidiasis of the oropharyngeal space in patients with HIV infection. Results of an open multicenter study of assessing the effectiveness and tolerance of fluconazole].

Tschechne B, Brunkhorst U, Ruhnke M, Trautmann M, Dempe S, Deicher H. Tschechne B, et al. Among authors: ruhnke m. Med Klin (Munich). 1991 Oct 15;86(10):508-11. Med Klin (Munich). 1991. PMID: 1758372 Clinical Trial. German.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

194 results

Search Page

Filters